Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal

1 Jan 2008

Abstract excerpt

Despite improvements in HIV treatment, the prevalence of multidrug resistance and full class resistance is still reported to be increasing. However, to investigate whether current treatment strategies are still selecting for multidrug and full class resistance, the incidence, instead of the prevalence, is more informative. Temporal trends in multidrug resistance (MDR defined as at most 1 drug fully susceptible)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to HIV/AIDS drug development and treatment
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18241328
DOI: 10.1186/1742-4690-5-12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in PortugalPMID 18241328Read ↗

HIV MDR is still a relevant issue despite its dramatic drop over the years.Semantic proximity Read ↗

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.Semantic proximity Read ↗

Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.Semantic proximity Read ↗

Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.Semantic proximity Read ↗

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.Semantic proximity Read ↗

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.Semantic proximity Read ↗

Temporal change in the use of genotypic resistance testing over the years 1999--2003.Semantic proximity Read ↗

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.